Vertex Pharmaceuticals has declined meaningfully from its most recent high. The company has several catalysts that could jolt the stock over the next year. The biotech's medium-term prospects appear ...

Biotech stocks returned up to 36% in 2025, while longevity investing hit $8.5B in funding. Here’s the data individual ...

Investors buying this biotech stock now will get its pipeline essentially for free.

Biotech firms are gaining major traction in 2026 due to the global pandemic. Take a look at some of the key features of ...

Biotech M&A surges in 2026, putting ABVX, IOVA, VKTX and BCRX on watchlists, as drugmakers seek late-stage and commercial ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it, the ...

While everyone else is staring at dot plots and hanging on Jensen Huang's every utterance, Illumina (ILMN) has been quietly doing what good charts do. It has been going up. The stock is bucking its ...

Investors have plenty of crosscurrents of news and economic stats to ponder when looking for new stocks these days, but the breakout in biotech stocks is one definite that has become clear, as ...

Legend Biotech has frequently been at the center of takeover rumors, and the stock regularly spikes on speculation that it has received formal buyout bids. It stands out as one of the most uniquely ...

Three biotech stocks in the IBD 50 are setting up in bases while a fourth is pulling back from highs as the first-quarter earnings season gets into full swing. Travere Therapeutics (TVTX), part of IBD ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...